Mary Hayden to Drug Resistance, Multiple, Bacterial
This is a "connection" page, showing publications Mary Hayden has written about Drug Resistance, Multiple, Bacterial.
Connection Strength
0.490
-
Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes. JAMA. 2024 05 14; 331(18):1544-1557.
Score: 0.220
-
Improving Empiric Antibiotic Selection for Patients Hospitalized With Abdominal Infection: The INSPIRE 4 Cluster Randomized Clinical Trial. JAMA Surg. 2025 Jul 01; 160(7):733-743.
Score: 0.060
-
Improving Empiric Antibiotic Selection for Patients Hospitalized With Skin and Soft Tissue Infection: The INSPIRE 3 Skin and Soft Tissue Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 01; 185(6):680-691.
Score: 0.059
-
Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial. JAMA. 2024 06 18; 331(23):2018-2028.
Score: 0.055
-
Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial. JAMA. 2024 06 18; 331(23):2007-2017.
Score: 0.055
-
The SHIELD Orange County Project: Multidrug-resistant Organism Prevalence in 21 Nursing Homes and Long-term Acute Care Facilities in Southern California. Clin Infect Dis. 2019 10 15; 69(9):1566-1573.
Score: 0.040